Subramanian Swamy Urges Ban on Cement Imports from Pakistan Citing Smuggling Risks Inflation Rate Projected to Hit 6 in Q2 According to Latest Economic Survey Japan Shipbuilding Town Turns to Foreign Workers and AI to Address Labor Crunch Alan Milburn Criticizes UK Welfare Spending on Youth as Shameful Amid Calls for Reform Federal Reserve May Struggle to Justify Interest Rate Cuts as Inflation Concerns Persist Music Catalogs Attract Institutional Capital as SonyGIC Joint Venture Acquires Recognition Music Group for 4 Billion TFSL Q1 2026 Earnings EPS Misses Estimates Slightly Amid Steady Operating Performance IMA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline Telomir Pharmaceuticals Inc TELO Q4 2025 Earnings WiderthanExpected Loss Highlights DevelopmentStage Challenges ACI Worldwide ACIW Q1 2026 Earnings EPS Surpasses Estimates Amid Solid Execution Belden Inc Q1 2026 Earnings EPS Surpasses Estimates Stock Slips JACK Q1 2026 Earnings EPS Slightly Misses Estimates but Stock Surges Over 8 Solidion Technology Inc STI Gains 357 as Stock Approaches Key Resistance American Coastal Insurance ACIC Holds Steady Near Support Amid Modest Decline First Majestic Silver AG Slides Amid Silver Weakness Key Levels in Focus Taseko Mines TGB Surges 746 as Copper Momentum Builds BCE Inc BCE Rallies Slightly Support and Resistance Levels in Focus Post Oak Group Identifies Middle Market as Key Growth Driver for 2026 MA GrafTech Q1 2026 Earnings EPS Miss Exceeds 40 Yet Stock Rebounds Highland Global Allocation Fund HGLB Slips 091 Holding Within Established Trading Range WF International WXM Edges Higher Resistance and Support Levels in Focus Apollomics Inc Warrant APLMW Holds Steady Near Minimal Levels A Closer Look at the Biotech Derivative Enovis Corporation ENOV Holds Near Support Amid Modest Decline PennantPark Floating Rate Capital PFLT Edges Higher Amid Stable Trading Volume Structure Therapeutics GPCR Shows Modest Gains as Biotech Sentiment Improves Constellation Brands STZ Nears Key Support as Stock Declines Marginally Abeona Therapeutics ABEO Slips 145 as Stock Tests Key Support at 517